Spectrum of chronic lung disease in a population of newborns with extremely low gestational age

O Hjalmarson1, H Brynjarsson, S Nilsson

  • 1Department of Paediatrics, The Sahlgrenska Academy at University of Gothenburg, Sweden. ola.hjalmarson@pediat.gu.se

Insights

Oxygenation difficulties are common in extremely low gestational age newborns (ELGANs). Lower gestational age and Apgar scores predict oxygenation problems in the first month, suggesting potential for early intervention.

Area of Science:

  • Neonatal physiology
  • Respiratory medicine
  • Pediatric pulmonology

Background:

  • Extremely low gestational age newborns (ELGANs) often experience respiratory challenges post-birth.
  • Understanding the development of blood oxygenation in ELGANs is crucial for managing their respiratory health.

Purpose of the Study:

  • To investigate the progression of blood oxygenation in ELGANs after birth.
  • To identify risk factors associated with the development of chronic lung disease in this vulnerable population.

Main Methods:

  • A prospective, population-based cohort study was conducted.
  • Alveolar-arterial oxygen pressure difference (AaDO(2)) was monitored in surviving infants.
  • Gestational age, Apgar scores, and need for mechanical ventilation were assessed.

Main Results:

  • Oxygenation deteriorated in over half of survivors after an initial period of normal lung function.
  • Low gestational age and low 5-minute Apgar scores were significant predictors of impaired oxygenation.
  • Mechanical ventilation was not identified as a risk factor for poor oxygenation.

Conclusions:

  • Impaired oxygenation is a prevalent issue among ELGANs, not limited to a specific subgroup.
  • Gestational age and Apgar score are independent predictors of oxygenation difficulties within the first month of life.
  • Further research into the pathogenesis of oxygenation failure may reveal opportunities for treatment or prevention.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...